Our analysis of the CYP3A7*1C allele, menopausal hormone treatment and breast cancer risk was inconclusive; while the carrier ORs were consistent with a greater protective effect of this allele in women taking exogenous hormones, particularly oestrogen–progesterone therapy, none of the interactions was statistically significant. This evidence concerns the gene CYP3A7 and breast carcinoma.